FR49M - Crystallized salts of substituted pyrrolidines - Google Patents

Crystallized salts of substituted pyrrolidines

Info

Publication number
FR49M
FR49M FR833900A FR833900A FR49M FR 49 M FR49 M FR 49M FR 833900 A FR833900 A FR 833900A FR 833900 A FR833900 A FR 833900A FR 49 M FR49 M FR 49M
Authority
FR
France
Prior art keywords
substituted pyrrolidines
crystallized salts
crystallized
salts
pyrrolidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR833900A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Application granted granted Critical
Publication of FR49M publication Critical patent/FR49M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR833900A 1959-07-27 1960-07-25 Crystallized salts of substituted pyrrolidines Expired FR49M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0054195 1959-07-27

Publications (1)

Publication Number Publication Date
FR49M true FR49M (en) 1960-11-28

Family

ID=6970521

Family Applications (1)

Application Number Title Priority Date Filing Date
FR833900A Expired FR49M (en) 1959-07-27 1960-07-25 Crystallized salts of substituted pyrrolidines

Country Status (2)

Country Link
FR (1) FR49M (en)
GB (1) GB915456A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2535700A (en) * 1999-02-12 2000-08-29 Novo Nordisk A/S Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation
EP1420781A2 (en) * 2001-08-29 2004-05-26 Endo Pharmaceuticals Inc. Analgetic pyrroline derivatives
RU2440115C2 (en) * 2009-11-19 2012-01-20 Общество С Ограниченной Ответственностью "Фармвинг" Coformulated drugs containing 2-ethyl-3-(n,n-dimethylcarbamoyloxy)-6-methylpyridine salts with organic and inorganic acids and succinic acid showing antihypoxic, antiamnestic and anticonvulsant activity

Also Published As

Publication number Publication date
GB915456A (en) 1963-01-16

Similar Documents

Publication Publication Date Title
BE586189A (en) Advanced box holder
FR78613E (en) Metal salt compositions
FR49M (en) Crystallized salts of substituted pyrrolidines
FR1198654A (en) Separation of metal salt mixtures
BE595617A (en) Process for the preparation of diaminoketone salts
BE591101A (en) Construction of transformers
FR1190714A (en) Purification of polyolefins
BE584976A (en) Quaternary salts of tropinic compounds
FR1269910A (en) Improvements to the crystallization of mineral salts
FR1184801A (en) Purification of lithium salts
BE628925A (en) Crystallization of diphenylolalkanes
FR1295340A (en) New phenanthridinium salts
FR1295342A (en) New phenanthridinium salts
FR1259510A (en) Table salt
FR1273937A (en) Brightening composition
FR1228043A (en) Advanced obstetrical instrument
FR741M (en) 1-Alkyl-4-aminoquinolinium salt
FR1308145A (en) Preparation of salt single crystals
FR1230384A (en) Metronome box
BE574204A (en) Sulfonyl-pyridazine derivatives
FR1243393A (en) Advanced box holder
FR1243275A (en) Metronome
FR1254545A (en) Marking of ingots
FI33539A (en) Process for the preparation of 1-alkyl-4-aminoquinaldinium salts
FR1286674A (en) Zeolite crystallized therein